Unasyn
Product Images NDC 0049-1515

5 FDA label images from Roerig · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Unasyn (NDC 0049-1515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Unasyn Bulk 01)

Chemical Structure (Unasyn Bulk 01)
Chemical structure of the active ingredient in Unasyn, depicting the molecular framework including a beta-lactam ring, a thiazolidine ring, an amino group, and a carboxylate sodium salt group.*
FDA Label Image

Chemical Structure (Unasyn Bulk 02)

Chemical Structure (Unasyn Bulk 02)
Chemical structure diagram of the active ingredient, corresponding to Unasyn. The diagram shows key molecular components including a beta-lactam ring, sodium carboxylate group, methyl groups, and a sulfone moiety, consistent with the known chemical structure of the drug's active compound.*
FDA Label Image

Logo (Unasyn Bulk 03)

FDA Label Image

Principal Display Panel (15 g Bulk Vial Label)

Principal Display Panel (15 g Bulk Vial Label)
Unasyn 15 g sterile powder for injection vial label by Roerig, a division of Pfizer. Contains ampicillin sodium and sulbactam sodium for intravenous use. The label instructs adding 92 mL sterile water or 0.9% sodium chloride for reconstitution, notes the concentration as 100 mg/mL ampicillin and 50 mg/mL sulbactam after dilution, and specifies that the reconstituted solution is not for direct infusion. Storage recommended below 86°F (30°C). NDC 0049-0024-28.*
FDA Label Image

Principal Display Panel (15 g Bottle Carton)

Principal Display Panel (15 g Bottle Carton)
Packaging label for Unasyn 15 g sterile powder for injection, containing ampicillin sodium and sulbactam sodium. The label indicates it is a pharmacy bulk package not for direct infusion, for intravenous use, distributed by Roerig, a division of Pfizer Inc. The package includes dilution instructions and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.